How many chapters are there in the regulations for the supervision and management of drug production
Different versions of the Regulations for the Supervision and Administration of Pharmaceutical Production had different chapters. The Regulations for the Supervision and Administration of Drug Production revised in 2020 consisted of 6 chapters and 81 articles; the new version of the Regulations for the Daily Supervision and Administration of Drug Production issued by Shandong Province since January 1,2022 consisted of 6 chapters and 62 articles. Read more exciting novels for free
What are the regulations for drug development?
In China, the regulations related to drug research and development were as follows: - The state supports the innovation of drugs that are oriented to clinical value and have clear or special effects on human diseases. It also supports the development of new drugs with new treatment mechanisms, treatment of serious life-threatening diseases or rare diseases, and multi-targeted systematic regulation and intervention functions for the human body, so as to promote the advancement of pharmaceutical technology. We should encourage the use of modern science and technology and traditional Chinese medicine research methods to carry out scientific and technological research and drug development of Chinese medicine, establish and improve a technical evaluation system that conforms to the characteristics of Chinese medicine, promote the inheritance and innovation of Chinese medicine, and take effective measures to encourage the development and innovation of children's drugs. - Those engaged in drug research and development activities should abide by the quality management regulations for non-clinical research and the quality management regulations for clinical trials of drugs to ensure that the whole process of drug research and development continues to meet the legal requirements. These two regulations were formulated by the drug supervision and administration department under the State Council in conjunction with the relevant departments under the State Council. - To carry out non-clinical studies of drugs, it is necessary to comply with the relevant national regulations, have personnel, sites, equipment, instruments, and management systems that are suitable for the research project, and ensure the authenticity of relevant data, information, and samples. - To carry out clinical trials of drugs, the research methods, quality indicators, pharmacology and toxicity test results and other data, materials and samples shall be truthfully submitted and approved according to the regulations of the drug supervisory and administrative department under the State Council. Among them, the drug administration department of the State Council shall decide whether to agree and notify the sponsor within 60 working days from the date of acceptance of the clinical trial application. Failure to notify the sponsor within the time limit shall be deemed as consent. If the bioequivalent trial is carried out, it shall be reported to the drug administration department of the State Council for filing. Drug clinical trials should be carried out in clinical trial institutions that meet the corresponding conditions. Drug clinical trial institutions shall be subject to filing management. The specific measures shall be jointly formulated by the drug administration department under the State Council and the competent health department under the State Council. - The clinical trial of drugs must be carried out in accordance with ethical principles, and the clinical trial plan must be formulated and approved by the ethics committee. The ethics committee should establish a working system to ensure that the review process is independent, objective, and fair, supervise the implementation of drug clinical trials, protect the legitimate rights and interests of the subjects, and safeguard the public interest. To conduct a clinical trial of a drug, it is necessary to truthfully explain the purpose and risks of the clinical trial to the subject or his guardian, obtain the informed consent form signed voluntarily, and take effective measures to protect the legitimate rights and interests of the subject. - During the clinical trial of a drug, if safety problems or other risks are found, the clinical trial sponsor shall promptly adjust the clinical trial protocol, suspend or terminate the clinical trial, and report to the drug administration department of the State Council. When necessary, the drug administration department under the State Council may order the adjustment, suspension or termination of clinical trials. - For drugs that are undergoing clinical trials to treat serious life-threatening diseases that have no effective treatment methods, if they may benefit from medical observation and conform to ethical principles, they can be used on other patients with the same condition in the institution where the clinical trial is conducted after review and informed consent. - Except for the Chinese herbal medicines and Chinese herbal slices that have not been approved and managed, the drugs listed in China should be approved by the drug supervision and administration department of the State Council and obtain the drug registration certificate. To apply for drug registration, one should provide true, sufficient and reliable data, information and samples to prove the safety, effectiveness and quality control of the drug. - For the drugs applied for registration, the drug supervision and administration department of the State Council would organize pharmaceutical, medical and other technical personnel to review the safety, effectiveness, and quality control of the drugs, as well as the quality management, risk prevention and control, and responsibility compensation of the applicants. If the conditions were met, a drug registration certificate would be issued. When approving drugs, the chemical raw materials, relevant auxiliary materials, packaging materials and containers that come into direct contact with the drugs shall be reviewed and approved together. The quality standards, production process, labels and instructions of the drugs shall be reviewed and approved together. - For the treatment of diseases that are seriously life-threatening and have no effective treatment methods, as well as drugs that are urgently needed in public health, if the clinical trials of the drugs have shown the efficacy and can predict their clinical value, they can be approved with conditions, and the relevant matters can be stated in the drug registration certificate. - The drug supervision and administration department under the State Council should improve the drug review and approval work system, strengthen capacity building, establish and improve communication and expert consultation mechanisms, improve the review and approval process, and improve the review and approval efficiency. The review conclusion and basis for the approval of drugs for marketing shall be made public according to law and subject to social supervision. In terms of industry management system: - As the drug supervision department, the State Drug Administration (NMPA) and its branches were responsible for the administrative management and technical supervision of the research, production, circulation and use of drugs. NMPA was mainly responsible for drug safety supervision and management, drafting supervision and management policy planning, drafting laws and regulations, drafting department rules and supervising their implementation, researching and formulating management and service policies to encourage new drug technologies and new products, responsible for drug standard management, registration management, quality management and post-marketing risk management, formulating inspection systems and organizing and guiding drug supervision and inspection. The Food and Drug Inspection Center of the State Food and Drug Administration was mainly responsible for organizing the formulation and revision of drug inspection system specifications and technical documents, and was responsible for drug clinical trials, qualification certification (certification) of non-clinical research institutions, on-site inspection of research and development, and on-site inspection of drug registration. The Center for Drug Evaluation of the State Drug Administration (CDe) is mainly responsible for the acceptance and technical review of drug clinical trials and drug marketing authorization applications, as well as the technical review of the evaluation of the quality and efficacy of generics. It also takes part in the formulation of relevant laws, regulations and standardized documents for drug registration management, as well as organizing the formulation of drug review specifications and technical guidelines, as well as organizing the implementation and coordination of inspections and tests related to drug review. - Our country implements self-discipline management for the production and operation of scientific research and technical service industries. The systems related to the Crow industry include the national drug standard system, the drug registration management system, the drug marketing authorization holder system, and the consistent evaluation system. - National drug standard system: National drug standards are mandatory technical guidelines and legal basis that must be followed in all aspects of drugs. Its system is based on the Drug Standard of the Ministry of Health of the People's Republic of China and the Chinese Pharmacopeias, the Drug Administration Law and the Administrative Methods for Drug Registration as the foundation, and the standards issued by the bureau/ministry as the extension. The Pharmacopeias Committee organized by the Drug Administration Department of the State Council is responsible for formulation and revision. - Drug registration management system: The State Food and Drug Administration/State Administration for Market Supervision and Administration will review the safety, effectiveness, and quality control of the drugs to be sold in accordance with the legal procedures according to the application of the drug registration applicants and decide whether to approve the application. Drug registration management follows the principles of publicity, fairness, and fairness. It is guided by clinical value, encouraging research and creation of new drugs, and actively promoting the development of generics. The relevant departments shall publish the list of drug registration and approval items, the basis, the approval requirements, and the time limit for handling according to law. They shall publicize the progress of drug registration, the review conclusions and basis for approving the drugs for marketing, as well as the illegal behaviors discovered in the supervision and inspection, and accept social supervision. In addition, there are clear regulations on the classification of chemical registration and the requirements for application materials. - Pharmaceutical Marketing Authority Holders (MAH): Pharmaceutical marketing authorization holders refer to the enterprises or pharmaceutical research and development institutions that have obtained the drug registration certificate. They shall be responsible for the non-clinical research, clinical trials, production and operation, post-marketing research, adverse reaction monitoring, reporting and handling of drugs in accordance with the regulations. Other relevant units and individuals shall bear corresponding responsibilities according to law. Under the MAH system, the marketing authorization and manufacturing authorization were independent of each other. The marketing authorization holder could be a variety of entities and could entrust the product to different manufacturers for production. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the requirements and regulations for the latest drug research and development regulations?
The state supports the innovation of drugs that are oriented to clinical value and have clear or special effects on human diseases. It also supports the development of new drugs with new treatment mechanisms, treatment of serious life-threatening diseases or rare diseases, and multi-targeted systematic regulation and intervention functions for the human body, so as to promote the advancement of pharmaceutical technology. We should encourage the use of modern science and technology and traditional Chinese medicine research methods to carry out scientific and technological research and drug development of traditional Chinese medicine, establish and improve the technical evaluation system that conforms to the characteristics of traditional Chinese medicine, promote the inheritance and innovation of traditional Chinese medicine, take effective measures to encourage the development and innovation of children's drugs, support the development of new varieties, dosage forms and specifications of children's drugs that conform to the physiological characteristics of children, and give priority to the review and approval of children's drugs. Those engaged in drug research and development activities should abide by the quality management standards for non-clinical research and clinical trials of drugs, and ensure that the entire process of drug research and development continues to meet the legal requirements. To carry out non-clinical research on drugs, there must be personnel, sites, equipment, instruments, and management systems suitable for the research project to ensure the authenticity of relevant data, materials, and samples. To carry out clinical trials of drugs, relevant data, materials and samples such as research and development methods, quality indicators, pharmacology and toxicity test results shall be submitted truthfully in accordance with the regulations and approved. It shall also be carried out in a clinical trial institution with corresponding conditions, and the institution shall implement filing management. The development of drug clinical trials must conform to ethical principles. The clinical trial protocol must be reviewed and approved by the ethics committee. The purpose and risks of the clinical trial must be truthfully explained to the subjects or their guardians, and the informed consent form must be obtained and their legal rights and interests must be protected. During the clinical trial of a drug, if safety problems or other risks are found, the clinical trial sponsor shall promptly adjust, suspend or terminate the clinical trial and report it. If necessary, the drug administration department may order the adjustment, suspension or termination of the clinical trial. For drugs that are undergoing clinical trials to treat serious life-threatening diseases that have no effective treatment methods, if they may benefit from medical observation and conform to ethical principles, they can be used on other patients with the same condition in the institution where the clinical trial is conducted after review and informed consent. For drugs listed in China, the drug registration certificate should be approved by the drug supervision and administration department (except for the Chinese medicinal materials and Chinese herbal slices that have not been approved and managed). The application for registration should provide data, information and samples that prove the safety, effectiveness and quality control of the drug. The drug administration department shall organize personnel to review the drugs applied for registration, and issue the drug registration certificate to those who pass the review. During the review and approval, the chemical raw materials shall be reviewed and approved at the same time, and the relevant auxiliary materials, packaging materials and containers that come into direct contact with the drugs shall be reviewed and approved at the same time. The quality standards, production process, labels and instructions of the drugs shall be reviewed and approved at the same time. For the treatment of diseases that are seriously life-threatening and have no effective treatment methods, as well as drugs that are urgently needed in public health, if the clinical trials of the drugs have shown the efficacy and can predict their clinical value, they can be approved with conditions, and the relevant matters can be stated in the drug registration certificate. Drug supervision and administration departments should improve the drug review and approval work system, strengthen capacity building, establish and improve communication, expert consultation and other mechanisms, and improve the review and approval process to improve the review and approval efficiency. In accordance with ICHQ10, establish a pharmaceutical quality system including research and development, regulate technology transfer and its processes and work content at each stage; carry out the development and production of bulk drugs in accordance with ICHQ11, including identifying potential key quality attributes of bulk drugs, determining a suitable manufacturing process, material attributes and the relationship between process parameters and key quality attributes of bulk drugs, identifying potential factors of process changes, determining critical decision trees and design space, etc. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
film management regulations
The Film Management Regulations were laws and regulations formulated to strengthen the management of the film industry and develop and prosper the film industry. It is applicable to the production, import, export, distribution and screening of feature films, documentaries, science and education films, art films, feature films, and other films within the territory of the People's Republic of China. According to the film management regulations, those engaged in film production, import, export, distribution and screening must abide by the Constitution and relevant laws and regulations, and adhere to the direction of serving the people and serving the country. The administrative department of radio, film and television under the State Council is in charge of the national film work, while the administrative departments of local people's governments above the county level are responsible for the film management work within their respective administrative areas. In addition, the film management regulations also stipulated that the production, import, export, distribution, screening and public screening of films should be subject to a permit system. In short, the purpose of the Film Management Regulations was to strengthen the management of the film industry, promote the development and prosperity of the film industry, meet the cultural needs of the people, and promote the construction of the material and spiritual civilization of the country.
New Regulations on Celebrity Management
What are the contents of the drug research phase regulations?
Drug development mainly had the following stages and relevant regulations: - ** Pre-clinical research stage **: Mainly includes the discovery and screening of new active ingredients, and the development of pharmacology and toxicity experiments (safety evaluation tests). - ** New drug clinical trial phase **: - ** Phase I clinical trial **: It is a preliminary clinical pharmacology and human safety evaluation test to observe the human body's tolerance to the new drug and its pharmacology, and to provide a basis for the formulation of the drug administration plan. The number of cases is 20 - 30. - ** Phase II clinical trial **: It is the preliminary evaluation stage of the treatment effect. The purpose is to preliminary evaluate the treatment effect and safety of the drug on patients with the target indication. It also includes providing a basis for the design of the phase III clinical trial and the determination of the dosage plan. The research design can be in various forms, such as a random blind controlled clinical trial. The number of cases should not be less than 100. - ** Phase III clinical trial **: It is the confirmation stage of the treatment effect. The purpose is to further verify the treatment effect and safety of the drug for patients with the target indication, evaluate the relationship between benefits and risks, and finally provide sufficient evidence for the review of the drug registration application. The trial should generally be a random, blind, controlled trial with sufficient sample size. According to the requirements of different diseases and dosage forms, the number of cases should not be less than 300. - ** Phase IV clinical trial **: It is the application research stage after the new drug is launched. The purpose is to investigate the efficacy and adverse reactions of the drug under widespread use conditions, evaluate the relationship between benefits and risks of using it in general or special populations, and improve the dosage. The number of cases shall not be less than 2000. - ** Bioequivalent test **: It refers to a human trial that uses the method of the study of the bio-utilization to compare the preparations of the same or different dosage forms of the same drug. Under the same test conditions, the degree and speed of absorption of the active ingredients are compared. Generally, 18 - 24 cases are involved. Generally, the development of a generic-type drug requires a bioequivalent test. - ** Production and post-marketing research phase **: The commercial production of drugs should comply with the Good Drug Production Practice, and the clinical use of drugs in the research and development phase should comply with the Good Drug clinical Trial Practice. During the R & D process, stability studies were carried out throughout the entire stage. It was necessary to follow relevant domestic and international regulations, such as ChP2020 <9001 Guidance on the stability testing of drug substances and preparations>, ChP2020 <9402 Guidance on the stability testing of biological products>, ICHQ1A-Q1E, relevant regulations of the World Health Organization, and 211.166 Stability testing of the Food and Drug Administration. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the drug production software?
The following are some drug production software: 1. Mass-MetaSite：A professional software specially designed for the identification of small molecules and peptide-based drugs. It can solve the difficulties of time-consuming manual analysis and complex data interpretation in traditional drug metabolism identification methods. It has improved efficiency (reducing analysis time from several hours to several minutes and supporting high-throughout batch processing), customized methods, intelligent structure prediction, fragment prediction, automatic generation of results, and special improvement in the processing ability of large molecules. 2. The pharmaceutical VR virtual simulation software developed by Beijing Opel: Taking Asparagine as an example, the virtual simulation training platform was built by combining Unity3D, C#, Maya and other technologies to simulate the production process of Asparagine. Its features included simulating the real production process with reference to the production environment of modern pharmaceutical factories, high experimental flexibility (breaking many restrictions), expanding experimental thinking, etc. It could assist medical students in learning and pharmaceutical company staff training, and reduce production costs. 3. According to the requirements of the Assessment Plan for the Professional Skill Level Certificate of Pharmaceutical Production, Obel developed the wet pellet compression virtual simulation software, the liquid preparation filling virtual simulation software, the sterile inspection virtual simulation software, the microscopic counting virtual simulation experiment software, and the controlled bacteria inspection virtual simulation experiment software. It could construct a realistic pharmaceutical production scene, flexibly evaluate the examinee's operation level and provide real-time feedback, making teaching and training more efficient and convenient. 4. The virtual simulation software for the production of freeze-dried preparations for injections (National Competition Version) developed by Beijing Opel: It is used for the drug production competition of the National Professional Skills Competition [Food, Drug and Grain Track II]. It accurately recreates the entire process of the production of freeze-dried preparations for injection, allowing users to comprehensively and deeply learn and master the operation skills of the six core positions, from A/B level personnel changing clothes, material weighing, liquid preparation, bottle washing and filling to freeze-drying. It can also build time components through data models, and convert time records and fill-ins into variables that can be monitored in real time. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What is the relationship between drug development and drug production?
Drug development and drug production were closely related. First of all, drug development was the prerequisite for drug production. The research and development work was aimed at exploring the nature and laws of human diseases, so as to develop effective drugs and treatment methods to prevent and treat diseases. Only through research and development could the key elements such as the composition, formula, and medicinal effects of the drug be determined before subsequent production could be carried out. For example, a new drug would only be ready for production after it had been proven to be safe and effective through pre-clinical research and clinical trials (including phase I, phase II, phase III, phase IV clinical trials, etc.). Secondly, drug production was the process of transforming and realizing the results of drug development. The production of drugs needed to be carried out according to the standards and processes determined by the drug development institute. The production process should follow the Good Manufacturing Practice (Good Manufacturing Practice). According to the approved production process, the raw materials, auxiliary materials, packaging materials, etc. that meet the requirements should be used to ensure that the produced drugs meet the national drug standards. At the same time, the quality inspection in the production process was also a kind of verification and guarantee for the research results. Moreover, the results of drug development could promote the advancement of drug production technology. The development of new drugs might be accompanied by the emergence of new technologies and processes, which would help improve the efficiency of drug production, improve the quality of drugs, and reduce production costs. For example, new pharmaceutical preparation technologies (such as complex injections with non-water-based solutions and nanotechnology) not only provided new solutions in drug research and development, but also provided new ideas for drug manufacturing. They simplified the preparation process steps, increased the degree of industrialization, improved the efficacy of drugs, and reduced side effects. Finally, drug production would also have a feedback effect on drug development. The problems encountered in the production process, such as the maneuverability of the production process, cost control, quality stability, and other aspects, could be fed back to the research and development department to promote the improvement and optimization of the research and development work, so as to further improve the overall quality and market competitiveness of the drug. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Market supervision laws and regulations e-book download website official website
The public can access the database of market supervision laws and regulations through the Internet. The website address is: <anno data-annotation-id ="00000000 - 4110 - 4440-sjfg.samr.gov.cn can also be accessed through the "Market Supervision Laws, Regulations and Regulations" module of the "Services" section of the portal website of the General Administration of Market Supervision. Mobile phone users can access it through the Weixin Official Accounts of "Shi Shuo Xin Yu" or download the "Municipal Supervision Regulations" app. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The responsibilities of the newspaper publishing management regulations
The responsibilities of the newspaper publication management regulations usually include the following aspects: 1. To ensure that the content of the newspaper is legal and compliant: The regulations on newspaper publication require that the newspaper must abide by relevant laws and regulations to ensure that the content does not violate national laws, regulations, and ethics. 2. To ensure the quality of the newspaper: The newspaper publishing management regulations require that the quality of the newspaper must be guaranteed, including the quality of printing, paper quality, ink quality, etc. 3. To ensure the authenticity and objectiveness of the newspaper: The newspaper publication management regulations require that the newspaper must maintain authenticity and objectiveness and must not fabricate or distort the facts. 4. Protecting the rights and interests of readers: The newspaper publishing management regulations require newspapers to protect the rights and interests of readers, including protecting the personal privacy of readers and protecting the information security of readers. 5. To ensure the distribution and circulation of newspapers: The regulations on the management of newspaper publication require that the circulation and circulation of newspapers must be legal and standardized.
Regulations on the Safety Management of Student Dormitory
The student dormitory safety management regulations cover many aspects: 1. ** Fire Safety Management Regulations ** - It is strictly forbidden to connect the power cord without permission. - It is strictly forbidden to place table lamps, terminal blocks, Walkmans, electric fans, charger and other electrical appliances that are prone to fire on flammable items such as bedding, mosquito nets, and cardboard boxes when they are connected to alternating current. - It is strictly forbidden to use or store appliances that are prone to fire danger in the student dormitory, such as refrigerator, air conditioner, rice cooker, electric hot pot, induction cooker, electric kettle, electric water boiler, and charging emergency light. - When leaving the dormitory, turn off the power and unplug the electrical load. - Smoking is strictly prohibited in the dormitory. - It is strictly forbidden to store and use candles in the apartment. - It is strictly prohibited to use open flames and burn things in the apartment. - It is strictly prohibited to use and store flammable, explosive, corrosive, toxic, and radioactive items in the apartment. - It is strictly prohibited to damage or use fire extinguisher and fire protection facilities without authorization (except when extinguishing fire). 2. ** Security and Safety Management Regulations ** - Outsiders were strictly prohibited from staying in the student dormitory. - Students should consciously abide by the school's schedule. Students are not allowed to return late or go out late at night without special circumstances. Students who return late or go out late at night must register in the duty room with valid documents and explain the situation. - Students should raise their awareness of safety and take good care of their belongings, especially valuables, to prevent loss and theft. - Students should lock the doors and windows when leaving the dormitory and keep the room keys. They are not allowed to lend the room keys to others. When leaving the dormitory or changing the dormitory, they should return the keys to the apartment management department. If the keys are lost, they should report to the management personnel in time. They are not allowed to change the locks and prepare the keys without permission. 3. ** Dormitory general safety regulations ** - Dangerous items such as knives, flammable and explosive items are prohibited in the dormitory. - In case of an emergency, such as physical discomfort or safety threats, you should immediately report to the dormitory management or call the emergency number. - Use network resources reasonably, abide by network ethics and laws and regulations, do not spread illegal information, and do not invade the privacy of others. - Regular safety education activities, including fire drills, first aid knowledge training, etc., were carried out to improve students 'safety awareness and self-protection ability. - Familiar with the dormitory's emergency evacuation routes and assembly points, and conduct evacuation drills regularly to ensure that they can evacuate quickly and safely in an emergency. 4. ** Special Item Management Regulations ** - It is strictly forbidden to use open flames in the dormitory, and it is not allowed to privately pull wires or use high-power electrical appliances. - Pay attention to safety when using electrical appliances and avoid overloading the socket. Turn off all power sources when leaving the dormitory to ensure the safety of electricity. 5. ** Personnel Management Regulations ** - Respect other people's privacy, keep the dormitory quiet, do not make a noise in the dormitory; abide by the rest time, turn off the lights and go to bed on time; do not engage in commercial activities or engage in illegal activities in the dormitory. - Personal belongings should be properly kept, and no one should borrow or misappropriate other people's property at will; valuables should be stored in a safe place, and the school will not bear the losses caused by personal improper safekeeping. - Non-dormitory members must be registered and approved by the dormitory management staff. Non-dormitory members are not allowed to stay overnight. - Any violation of the dormitory management regulations will be punished according to the relevant regulations of the school. Serious violators will be disqualified from accommodation.